Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Mar 04 2025

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 3 pages · English

Summary by 6ix AI

Zydus Lifesciences Limited has announced a press release regarding the development of a combination vaccine for shigellosis and typhoid, aimed at infants and children, supported by the Gates Foundation. This initiative highlights India's innovation capabilities in addressing critical public health issues related to enteric diseases. The project will involve early-stage development and regulatory studies, with collaboration for research and co-development of the vaccine. Dr. Sharvil Patel, Managing Director, emphasized the commitment to providing affordable vaccines to improve global public health.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 04, 2025, titled "Zydus, supported by the Gates Foundation, to develop the world s first combination vaccine to offer protection against shigellosis and typhoid for infants and children".

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases